Xianglin Hu
-
- HER2/EGFR in Cancer Research 3
- CAR-T cell therapy research 2
- Cancer Immunotherapy and Biomarkers 2
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Lung Cancer Diagnosis and Treatment 3
- Advanced Breast Cancer Therapies 2
- Pleural and Pulmonary Diseases 2
- Respiratory Support and Mechanisms 2
- Co-authors
- Yangbai SunDong YangYun FengYuanlin SongLu WangJing XuChaomin WuYue Shen
- Journals
- SHILAP Revista de lepidopterología (1 paper)Annals of Oncology (3 papers)Signal Transduction and Targeted Therapy (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Xianglin Hu
19 papers receiving 300 citations
Peers
Comparison fields: 5 of 72
- Infectious Diseases 114
- Neurology 72
- Critical Care and Intensive Care Medicine 17
- Oncology 80
- Cancer Research 43
Countries citing papers authored by Xianglin Hu
This map shows the geographic impact of Xianglin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianglin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianglin Hu more than expected).
Fields of papers citing papers by Xianglin Hu
This network shows the impact of papers produced by Xianglin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianglin Hu. The network helps show where Xianglin Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xianglin Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 2 | |
| 5 | Low Eosinophil Phenotype Predicts Noninvasive Mechanical Ventilation Use in Patients with Hospitalized Exacerbations of COPD | 2022 | 5 |
| 6 | 2022 | 4 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 26 | |
| 10 | 2020 | 2 | |
| 11 | 2020 | 139 | |
| 12 | 2020 | 8 | |
| 13 | 2019 | 16 | |
| 14 | 2019 | 2 | |
| 15 | 2019 | 6 | |
| 16 | 2018 | 9 | |
| 17 | 2018 | 4 | |
| 18 | 2018 | 5 | |
| 19 | 2013 | 50 | |
| 20 | 2008 | 19 |
About Xianglin Hu
Xianglin Hu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Critical Care and Intensive Care Medicine, having authored 20 papers that have together received 303 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), HER2/EGFR in Cancer Research (3 papers), Advanced Breast Cancer Therapies (2 papers), CAR-T cell therapy research (2 papers), Pleural and Pulmonary Diseases (2 papers), Respiratory Support and Mechanisms (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Infectious Diseases (114 citations), Neurology (72 citations) and Critical Care and Intensive Care Medicine (17 citations). Xianglin Hu has collaborated with scholars based in China, United States and India. Frequent co-authors include Yangbai Sun, Dong Yang, Yun Feng, Yuanlin Song, Lu Wang, Jing Xu, Chaomin Wu, Yue Shen, Chunling Du and Wangjun Yan. Their work appears in journals such as SHILAP Revista de lepidopterología, Annals of Oncology and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.